RA
ASMB icon

Raffles Associates’s Assembly Biosciences ASMB Stock Holding History

Raffles Associates’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-8,333
Closed -$388K – 44
2021
Q2 		$388K Buy
8,333
+4,166
+100% +$206K 0.33% 37
2021
Q1 		$230K Buy
+4,167
New +$276K 0.23% 33

Other funds holding ASMB

AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Raffles Associates's ASMB Position: Q3 2021 in Review

Raffles Associates sold out of Assembly Biosciences (ASMB) in Q3 2021, closing a stake of 8,333 shares — an estimated $388K sold.

Raffles Associates first reported a position in ASMB in Q1 2021 and held it in 2 quarters. The position peaked at $388K in Q2 2021. 65 funds tracked by Wall St. Rank hold ASMB as of Q3 2021.

  • Raffles Associates reported no remaining Assembly Biosciences position as of Q3 2021 after selling out during the quarter.
  • Raffles Associates sold 8,333 Assembly Biosciences shares in Q3 2021, an estimated $388K.
  • Raffles Associates first reported a position in Assembly Biosciences in Q1 2021 and held it in 2 quarters.
  • Raffles Associates's Assembly Biosciences position peaked at $388K in Q2 2021.
  • 65 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2021.

Based on Raffles Associates's 13F filing for Q3 2021, filed 16 Nov 2021.